PUNE, India, June 14, 2023 /PRNewswire/ — According to a recent market study published by Growth Market Reports, titled, “Global Subdermal Contraceptive Implants Market Segments – By Type (Jadelle, Sino-implant, and Nexplanon), By End-user (Hospitals, Clinics, and Others), and Region: Size, Share, Trends and Opportunity Analysis, 2023-2031“, the market size was USD 1.04 billion in 2022 and is expected to surpass USD 2.16 billion expanding at a CAGR of 8.4% by the end of 2031. The market is propelled by rising sexual and reproductive health awareness during the forecast period.
Key Market Players Profiled in the Report
- Merck & Co., Inc (Organon & Co.)
- Bayer AG
- Shanghai Dahua Pharmaceutical Co., Ltd
Download PDF Sample here: https://growthmarketreports.com/request-sample/4305
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include type, end-user, and competitor analysis.
This report also includes a complete analysis of industry players and covers their latest developments, product portfolio, pricing, mergers, acquisitions, and collaborations. Moreover, it provides crucial strategies that are helping market players to expand their market share.
For Any Questions on This Report: https://growthmarketreports.com/enquiry-before-buying/4305
Segment Highlights:
On the basis of region, the global subdermal contraceptive implants market is classified as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Middle East & Africa is projected to dominate the global market owing to the rising preference for implantable contraceptives over traditional methods.
North America is expected to be a rapidly growing region in the global market during the projected period due to the growing technological advancements in contraceptive science.
To Buy the Complete Report: https://growthmarketreports.com/report/subdermal-contraceptive-implants-market-global-industry-analysis
Key Takeaways from the Study:
- Subdermal contraceptive implant is a flexible rod that slowly releases a progestogen hormone to prevent pregnancy for a long period, ranging from three to five years.
- It is inserted subdermally, under local anesthesia using a trocar in the inner aspect of the non-dominant arm.
- The demand for long-term and effective birth control solutions is anticipated to fuel the market in the coming years.
- Few side effects with high efficacy are expected to drive the market during the forecast period.
- The Jadelle segment is projected to expand at the fastest CAGR during the forecast period as it is a reversible contraceptive that inhibits pregnancy for up to 5 years.
- The hospitals segment is anticipated to hold a major revenue share of the market, as the insertion of contraceptives under the arm skin is difficult to perform by patients and requires professional medical practitioners to install the device safely.
Read 166 Pages Research Report with Detailed TOC on “Global Subdermal Contraceptive Implants Market Segments – by Type (Jadelle, Sino-implant, and Nexplanon), By End-user (Hospitals, Clinics, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast, 2023 – 2031″
Get Full Access to this Report: https://growthmarketreports.com/checkout/4305
Key Segments Covered
Type
- Jadelle
- Sino-implant
- Nexplanon
End-user
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Other Related Reports:
- Africa Contraceptives Market Segments – by Products (Drugs [Tropical Contraceptives, Oral Contraceptives, and Contraceptive Injectable] and Devices [Diaphragms, Sponges, IUD, Condoms, Cervical Caps, Vaginal Rings, and Others]), Gender (Female and Male), and Region – Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
- Global Contraceptives Drugs and Devices Sales Market by Type (Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives), Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)), By Application (Female, Male) and Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa), Forecast From 2022 To 2030
- Global Combined Hormonal Contraceptives Market by Type (15-24 years, 25-34 years, 35-44 years, Above 44 years), By Application (Hospitals, Household, Clinics), and Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa), Forecast To 2028
- Global Contraceptive Pills Market by Type (Oral Contraceptives, Contraceptive Injectable), By Application (Online, Offline) and Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa), Forecast From 2022 To 2030
About Growth Market Reports:
Growth Market Reports provides global enterprises as well as small & medium businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. Growth Market Reports has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.
Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, and secondary research & consumer surveys.
Contact:
Alex Mathews
7th Floor, Siddh Icon,
Baner Road, Pune.
Maharashtra – 411045. India.
Phone: +1 909 414 1393
Email: [email protected]
Web: https://growthmarketreports.com/
Twitter: https://twitter.com/growth_reports
LinkedIn: https://www.linkedin.com/company/growth-market-report/
Logo : https://mma.prnewswire.com/media/1980656/Growth_Market_Reports_Logo1.jpg
SOURCE Growth Market Reports
